New Zealand Shares Rise on Health Tech Stocks' Gains; Skycity Asked to Pay NZ$4 Million in Penalty

MT Newswires Live09-26

New Zealand shares advanced on Thursday, buoyed by gains from health technology stocks.

The S&P/NZX 50 Index rose 2.2%, or 267.1 points, to close at 12,491.58.

Health technology shares led the rally with a 3.9% increase. Pacific Edge (ASX:PEB, NZE:PEB) rose nearly 12% as the cancer diagnostics company awaited a US decision on the Medicare coverage status for its Cxbladder tests.

On the data front, the BusinessNZ Economic Conditions Index stood at 8 for the three months to September, up 13 on the previous quarter, suggesting persisting macro headwinds despite a slight improvement.

The country's official reserve assets fell to NZ$32.57 billion in August from NZ$35.65 billion in July, data from the Reserve Bank of New Zealand showed.

In other corporate news, the High Court of New Zealand asked Skycity Entertainment Group's (ASX:SKC, NZE:SKC) SkyCity Casino Management to pay NZ$4.2 million in civil penalty for historic breaches of anti-money laundering and counter-terrorism financing act. The company's shares were up nearly 6% at market close.

The Warehouse Group (NZE:WHS) saw its adjusted earnings per share fall more than 67% to NZ$0.055 in the 52 weeks ended July 28 from NZ$0.166 a year ago.

Fletcher Building (NZE:FBU, ASX:FBU) opened the retail component of its NZ$418 million 1-for-4.49 pro-rata accelerated non-renounceable entitlement offer. The homebuilder's shares were down almost 2% at market close.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment